Everyone involved in the treatment of substance use disorder (SUD) and opioid use disorder (OUD) plays a critical role. Here are some of their experiences.

Addiction is persistent

See how reSET and reSET-O can help.

PATIENT STORIES

Heidi, reSET-O patient, video thumbnail

Heidi’s Story

It can happen to anybody. Never in my wildest dreams did I believe I’d be sitting here saying I did heroin. I started doing drugs at 53 years old.

Heidi, reSET-O patient

Colleen, reSET-O patient, video thumbnail

Colleen’s Story

I was taking opiates for chronic pain problems. I started taking more of them after my brother died. I felt that they made me feel normal, but I realized there’s a better way.

Colleen, reSET-O patient

Tara, reSET-O patient, video thumbnail

Tara’s Story

I’ve got 4 kids. I couldn’t get out of bed unless I popped a pill in the morning. reSET-O helped me. I’ve been clean for 2 years now.

Tara, reSET-O patient

These are the experiences of certain patients. Results may vary.

FOR HEALTHCARE PROFESSIONALS

patients and providers video thumbnail

Patients & Providers

With reSET-O, we have an opportunity to uniformly offer an evidence-based treatment. As a physician, to be able to say, ‘Look, I do have something that I can give you, that we can incorporate into your overall treatment that may be a benefit’ makes me feel like I’m doing something for the patient.

Improving Access With Crossroads Treatment Centers video thumbnail

Improving Access With
Crossroads Treatment Centers

Our collaboration with Pear means more people will get access to the support they need to fight opioid addiction.

reSET-O: Rethinking Treatment for Opioid Use Disorder video thumbnail

reSET: Rethinking Treatment for
Substance Use Disorder

For individuals with SUD, reSET® is the first FDA-authorized prescription digital therapeutic (PDT) clinically proven to help patients improve abstinence and stay in treatment longer. It works in conjunction with in-person or remote therapy to reinforce new ways of thinking to support recovery.1-2

reSET-O: Rethinking Treatment for Opioid Use Disorder video thumbnail

reSET-O: Rethinking Treatment for
Opioid Use Disorder

For individuals with opioid use disorder, reSET-O® is the only FDA-authorized PDT clinically proven to help patients stay in treatment longer. It works with buprenorphine medication-assisted therapy to reinforce new ways of thinking and can increase the chances for success with recovery.3

These are the experiences of certain healthcare professionals and treatment centers. Results may vary.

About reSET and reSET-O

resources graphic

Overview

Learn how reSET and reSET-O can help your patients.

technology integrations graphic

Integrations

See how to integrate PDTs into your practice.

prescribe seamlessly graphic

Prescribing Seamlessly

Watch how to streamline the prescribing process.

staying connected graphic

Staying Connected

Discover how the clinician dashboard provides patient insights.

reSET® Indications for Use:

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older, who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 day) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse.

It is intended to:

  • increase abstinence from a patient’s substances of abuse during treatment, and
  • increase retention in the outpatient treatment program.

reSET® Important Safety Information for Clinicians:

Warnings: reSET is intended for patients whose primary language is English with a reading level of 7th grade or above, and who have access to an Android/iOS tablet or smartphone. reSET is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET is not intended to be used as a stand-alone therapy for substance use disorder (SUD). reSET does not replace care by a licensed medical practitioner and is not intended to reduce the amount of face-to-face clinician time. reSET does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider.

Patients with substance use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population. Patients with substance use disorder also have higher baseline rates of suicidal ideation, and suicide attempts, and suicide completion. Clinicians should engage in their normal care practices to monitor patients for medical problems and mental health disorders, including risk for harming others and/or themselves.

The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks (90 days) in the SUD population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied.

The effectiveness of reSET has not been demonstrated in patients currently reporting opioids as their primary substance of abuse.

Please see the Clinician Brief Summary Instructions for reSET.

reSET-O® Indications for Use:

reSET-O prescription digital therapeutic is a 12-week (84 day) software application intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

reSET-O® Important Safety Information for Clinicians:

Warnings/precautions: reSET-O is intended for patients whose primary language is English with a reading level of 7th grade or above, and who have access to an Android/iOS tablet or smartphone. reSET-O is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET-O to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET-O to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET-O is not intended to be used as a stand-alone therapy for Opioid Use Disorder (OUD). reSET-O does not replace care by a licensed medical practitioner and is not intended to reduce the frequency or duration of in-person therapy. reSET-O does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider.

Patients with opioid use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population. Patients with opioid use disorder have higher baseline rates of suicidal ideation, and suicide attempts, and suicide completion. Clinicians should undertake standard of care to monitor patients for medical problems and mental health disease, including risk for harming others and/or themselves.

The long-term benefit of reSET-O has not been evaluated in studies lasting beyond 12 weeks (84 days) in the OUD population. The ability of reSET-O to prevent potential relapse after therapy discontinuation has not been studied.

Please see the Clinician Brief Summary Instructions for reSET-O.